Wilson Sonsini Goodrich & Rosati is pleased to present the full-year 2023 edition of The Entrepreneurs Report. We’ve compiled a range of data on venture, convertible note, and SAFE financing transactions in which the firm was involved during 2023, with the objective of identifying relevant trends in activity and valuation levels for the U.S. venture capital industry in general. In addition, this issue features a Q&A with Wilson Sonsini partner Seth Helfgott, who focuses on corporate and securities law, including...

Read more

Amid a light news stream, the dollar is mostly in narrow ranges against the G10 currencies. Leaving aside the Norwegian krone, the others in a +/- 0.15% against the dollar today. We note that the technical tone of the euro and sterling have improved withe the five-day moving averages crossing above the 20-day moving averages. On the other hand, the dollar is approaching the year's low set last week near JPY150.90. Emerging market currencies are mostly lower, On the...

Read more

The Innovative Brand is Set to Pave the Way for Unprecedented Gaming Excellence and Innovation in the Keystone State. Supremeland Gaming, Inc., the dynamic and in- novative iGaming challenger, is thrilled to announce the attainment of its first-ever gaming ap- proval in the United States, marking a significant milestone in the company's expansion strategy. The studio has received official Interim Authorization from the state of Pennsylvania, a key market for the gaming industry in the United States. The approval allows Supremeland...

Read more

The European Commission has announced a significant milestone in the economic trajectory of the European Union with the agreement reached between the European Parliament and the Council on a comprehensive reform of the EU’s economic governance framework. This agreement marks the most ambitious reform since the aftermath of the economic and financial crisis, indicating a pivotal moment in shaping the future of the EU’s economic landscape. Following the presentation of reform proposals by the Commission in April 2023, the new framework aims...

Read more

Healthy activity levels expected in 2024 2023 was a reasonably strong year for the pharmaceutical and life sciences sector with both deal value and volume of M&A close to pre-pandemic levels. In 2024, we expect similar levels of activity, in the $225 billion to $275 billion range across all subsectors. Executives will continue to deploy cash balances and seek out areas of innovation and clinical differentiation to help address remaining growth challenges in the latter half of the decade. Despite some...

Read more

Welcome to “Lost in Translation: Blunders in International Estate Planning.” This blog series explores the rarified world of international estate planning, uncovering potential pitfalls and providing insights to navigate the complexities. Blunder No. 2: Overlooking the Role of Cash as King There are numerous proverbs and sayings regarding money: You can’t take it with you. Money makes the world go round. Throwing good money after bad. Money talks. Time is money. A penny for your thoughts. A fool and his money are soon parted. Money does not grow on...

Read more

As manufacturers start their strategic planning for 2024, they should pay attention to labor, economic climate, cybersecurity, and customers satisfaction: Labor and digital development Hiring and retaining quality skilled employees has never been more difficult. Like 2023,  organizations are predicting tight labor markets will continue to constrain growth in 2024. Burnout, low morale, insufficient wages, life balance, early retirement, increased union activities, contract labor disputes, and higher cost of living will continue to create headwinds. What can you do? • Pay close attention...

Read more